shutterstock_1426857821

Aeglea BioTherapeutics and Immedica Announce Commercialization

Aeglea BioTherapeutics, Inc. (NASDAQ:AGLAeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzymeE), a clinical-stage biotechnology company developing a new generation of human enzyme